KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership439,099 shares
Latest Disclosed Value $ 8,839,072
Morgan Stanley reports 37.29% decrease in ownership of 4XC1 / KalVista Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 439,099 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $6,806,034 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 700,228 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of -37.29% during the quarter. The current value of the position is $10,103,668 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 439,099 -261,129 -37.29 8,839 -21.83 0.0005
2026-05-27 2025-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 700,228 135,372 23.97 11,309 64.38 0.0007
2026-02-13 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 700,228 135,372 11,309 0.0007
2026-05-27 2025-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 564,856 325,227 135.72 6,880 153.93 0.0004
2025-11-14 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 564,856 325,227 6,880 0.0004
2025-08-15 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 239,629 15,840 7.08 2,709 4.92 0.0002
2025-05-15 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 223,789 -65,726 -22.70 2,583 5.30 0.0002
2025-05-15 2024-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 289,515 -7,887 -2.65 2,452 -28.78 0.0002
2025-02-14 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 289,515 -7,887 2,452 0.0002
2025-05-14 2024-09-30 13F/A-2 KALVISTA PHARMACEUTICALS COM 483497103 297,402 -41,182 -12.16 3,444 -13.67 0.0002
2025-02-14 2024-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 297,402 -41,182 3,444 0.0002
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 297,402 -41,182 3,444 0.0002
2025-05-14 2024-06-30 13F/A-2 KALVISTA PHARMACEUTICALS COM 483497103 338,584 -85,850 -20.23 3,989 -20.76 0.0003
2024-10-17 2024-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 338,584 -85,850 3,989 0.0003
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 338,584 -85,850 3,989 0.0003
2024-10-17 2024-03-31 13F/A-2 KALVISTA PHARMACEUTICALS COM 483497103 424,434 -28,000 -6.19 5,034 -9.18 0.0004
2024-08-16 2024-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 424,434 -28,000 5,034 0.0004
2024-05-15 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 424,434 -28,000 5,034 0.0004
2024-08-16 2023-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 452,434 242,506 115.52 5,542 174.22 0.0005
2024-02-13 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 452,434 242,506 5,542 0.0005
2023-11-15 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 209,928 7,305 3.61 2,022 10.86 0.0002
2023-08-14 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 202,623 10,847 5.66 1,824 20.97 0.0002
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 191,776 -641,977 -77.00 1,507 -73.26 0.0002
2023-02-14 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 833,753 802,871 2,599.80 5,636 1,158.04 0.0006
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 30,882 -28,437 -47.94 448 -23.29 0.0001
2022-10-27 2022-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 59,319 -8,060 -11.96 584 -41.19 0.0001
2022-08-15 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 59,319 -8,060 584 0.0001
2022-10-27 2022-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 67,379 4,295 6.81 993 18.92 0.0001
2022-05-13 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 67,379 4,295 993 0.0001
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 63,084 45,963 268.46 835 178.33 0.0001
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 17,121 7,306 74.44 300 27.66 0.0000
2021-08-23 2021-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 9,815 -20,000 -67.08 235 -69.32 0.0000
2021-08-16 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 9,815 -20,000 235 0.0000
2021-05-17 2021-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 29,815 17,513 142.36 766 228.76 0.0001
2021-02-16 2020-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 12,302 7,250 143.51 233 269.84 0.0000
2020-11-13 2020-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 5,052 -1,127 -18.24 63 -16.00 0.0000
2020-08-14 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 6,179 -13,613 -68.78 75 -50.33 0.0000
2020-05-26 2020-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 19,792 896 4.74 151 -55.19 0.0000
2020-05-15 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 19,792 896 151 11.5999
2020-02-14 2019-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 18,896 -19,423 -50.69 337 -24.10 0.0001
2019-11-14 2019-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 38,319 37,378 3,972.16 444 2,014.29 0.0001
2019-08-14 2019-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 941 -6,545 -87.43 21 -90.19 0.0000
2019-05-15 2019-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 7,486 6,636 780.71 214 1,158.82 0.0001
2019-02-14 2018-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 850 -3,352 -79.77 17 -81.72 0.0000
2019-04-23 2018-09-30 13F/A-2 KALVISTA PHARMACEUTICALS COM 483497103 4,202 3,438 450.00 93 1,450.00 0.0000
2018-11-20 2018-09-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 4,202 0 93 0.0000
2018-11-14 2018-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 4,202 3,438 93
2019-04-23 2018-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 764 723 1,763.41 6 -93.55 0.0000
2018-08-14 2018-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 764 723 6
2019-04-23 2018-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 41 0 0.00 0 -100.00 0.0000
2018-05-14 2018-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 41 0 0
2019-04-23 2017-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 41 0 0.00 0 0.0000
2018-02-14 2017-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 41 0 0
2017-11-14 2017-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 41 -159 -79.50 0 -100.00
2017-08-11 2017-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 200 0 0.00 1 0.00 0.0000
2017-05-22 2017-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 200 0 0.00 1 0.00 0.0000
2017-05-12 2017-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 200 1
2017-02-22 2016-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 200 200 1 0.0000
2017-02-13 2016-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 200 1
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.